Editorial: The molecular landscape and promising therapeutic targets in aggressive B-cell non-Hodgkin lymphomas

被引:0
|
作者
Witte, Hanno Maximilian [1 ,2 ,3 ]
Kuenstner, Axel [3 ,4 ]
Chteinberg, Emil [5 ,6 ]
Piazza, Francesco [7 ,8 ]
Roue, Gael [9 ]
Gebauer, Niklas [2 ,3 ]
机构
[1] Bundeswehrkrankenhaus Ulm, Dept Hematol & Oncol, Ulm, Germany
[2] Univ Hosp Schleswig Holstein, Dept Hematol & Oncol, Lubeck, Germany
[3] Univ Hosp Schleswig Holstein, Univ Canc Ctr Schleswig Holstein, Lubeck, Germany
[4] Univ Lubeck, Med Syst Biol Grp, Lubeck, Germany
[5] Ulm Univ, Inst Human Genet, Ulm, Germany
[6] Ulm Univ, Med Ctr, Ulm, Germany
[7] Univ Padua, Dept Med, Hematol & Clin Immunol Unit, Padua, Italy
[8] Veneto Ist Mol Med, Myeloma & Lymphoma Pathobiol Lab, Padua, Italy
[9] Josep Carreras Leukaemia Res Inst, Lymphoma Translat Grp, Badalona, Spain
来源
FRONTIERS IN ONCOLOGY | 2023年 / 13卷
关键词
aggressive B-cell lymphoma; non-Hodgkin lymphoma; genomics; transcriptomics; multi-omics; precision oncology;
D O I
10.3389/fonc.2023.1278169
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Targeted Agents in the Treatment of Indolent B-Cell Non-Hodgkin Lymphomas
    Minson, Adrian
    Tam, Constantine
    Dickinson, Michael
    Seymour, John F.
    CANCERS, 2022, 14 (05)
  • [42] Eupafolin induces autophagy and apoptosis in B-cell non-Hodgkin lymphomas
    Chen, Zui
    Cheng, Long Qiu
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2021, 73 (02) : 241 - 246
  • [43] Outcome of treatment to the B-ALL protocol in patients with aggressive B-cell non-Hodgkin's lymphomas.
    Övermann, K
    Peest, D
    Ganser, A
    ANNALS OF ONCOLOGY, 2000, 11 : 107 - 107
  • [44] Immunotherapeutic concepts for aggressive B-cell non-Hodgkin's Lymphoma
    Krackhardt, A.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 10 - 11
  • [45] Patterns of immune checkpoint protein expression in MYC-overexpressing aggressive B-cell non-Hodgkin lymphomas
    Landsburg, Daniel J.
    Koike, Alexa
    Nasta, Sunita D.
    Svoboda, Jakub
    Schuster, Stephen J.
    Wasik, Mariusz A.
    Caponetti, Gabriel C.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021, 70 (03) : 869 - 874
  • [46] EVALUATION OF ROUTINE COMPUTED TOMOGRAPHY IN THE FOLLOW-UP OF AGGRESSIVE B-CELL NON-HODGKIN'S LYMPHOMAS
    Mascaro-Pol, M.
    Diez-Feijoo, R.
    Rodriguez-Sevilla, Jj
    Fernandez-Rodriguez, C.
    Garcia-Pallarols, F.
    Flores, S.
    Vazquez, I
    Rodriguez-Lopez, S.
    Roman, D.
    Pinzon, S.
    Gimeno, E.
    Colomo, L.
    Maiques, J.
    Sanchez-Gonzalez, B.
    Salar, A.
    HAEMATOLOGICA, 2021, 106 (10) : 291 - 291
  • [47] Analysis of prognostic factors in patients with HIV-associated aggressive B-cell non-Hodgkin lymphomas.
    Mathew, Blessy Maria
    Dalia, Samir
    Hall, Joseph
    Kuykendall, Andrew
    Shah, Bijal D.
    Bello, Celeste M.
    Chervenick, Paul A.
    Sokol, Lubomir
    Sotomayor, Eduardo M.
    Chavez, Julio C.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [48] Patterns of immune checkpoint protein expression in MYC-overexpressing aggressive B-cell non-Hodgkin lymphomas
    Daniel J. Landsburg
    Alexa Koike
    Sunita D. Nasta
    Jakub Svoboda
    Stephen J. Schuster
    Mariusz A. Wasik
    Gabriel C. Caponetti
    Cancer Immunology, Immunotherapy, 2021, 70 : 869 - 874
  • [49] Genomic landscape of adult and paediatric B-cell Non-Hodgkin lymphoma
    Newman, Alexander M.
    Zhou, Peixun
    Zaka, Masood
    Harrison, Christine J.
    Bomken, Simon
    Bacon, Chris M.
    Rand, Vikki
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 182 : 69 - 69
  • [50] Mast cell heterogeneity in B-cell non-Hodgkin's lymphomas: An ultrastructural study
    Crivellato, E
    Nico, B
    Vacca, A
    Dammacco, F
    Ribatti, D
    LEUKEMIA & LYMPHOMA, 2002, 43 (11) : 2201 - 2205